Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs34379626 | chr14:74640972 | A/G | 0.000221 | 176 | 25.28 | 26.57 | 10.57 | KM Plot |
PCPG | rs34382843 | chr13:37543479 | G/GTC | 0.000366 | 174 | 4.17 | 24.17 | 25.87 | KM Plot |
PCPG | rs34409294 | chr17:50290356 | A/G | 6.66E-5 | 177 | 25.77 | 27.95 | 14.47 | KM Plot |
PCPG | rs34413179 | chr12:31790828 | A/G | 0.000345 | 175 | 24.6 | 28.3 | 16.83 | KM Plot |
PCPG | rs34420680 | chr16:89809171 | C/T | 0.000191 | 173 | 26.22 | 20.2 | 36.37 | KM Plot |
PCPG | rs34421862 | chr14:74307623 | T/G | 4.2E-6 | 175 | 25.47 | 27.2 | 10.43 | KM Plot |
PCPG | rs34423852 | chr2:242561703 | A/C | 3.52E-5 | 173 | 25.2 | 25.67 | 20.28 | KM Plot |
PCPG | rs34433766 | chr14:74305307 | T/G | 4.2E-6 | 175 | 25.47 | 27.2 | 10.43 | KM Plot |
PCPG | rs34434571 | chr3:150883777 | A/AT | 0.000417 | 173 | 24.85 | 29.43 | 60.03 | KM Plot |
PCPG | rs34436589 | chr21:38496374 | TA/T | 1.11E-16 | 174 | 24.7 | 25.63 | 3.17 | KM Plot |
PCPG | rs34440436 | chr14:74485133 | C/T | 3.72E-7 | 178 | 25.28 | 28.38 | 7.4 | KM Plot |
PCPG | rs34441975 | chr2:242584876 | T/A | 7.68E-11 | 174 | 25.77 | 24.7 | 10.3 | KM Plot |
PCPG | rs34445440 | chr17:74668773 | CTG/C | 1.3E-6 | 171 | 25.53 | 24.23 | 10.28 | KM Plot |
PCPG | rs34449944 | chr2:242546309 | C/A | 4.87E-11 | 177 | 25.87 | 24.07 | 10.3 | KM Plot |
PCPG | rs34474101 | chr15:43187460 | A/G | 2.58E-14 | 175 | 25.87 | 24.62 | 3.17 | KM Plot |